세계의 간질 모니터링 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Epilepsy Monitoring Devices Market Trends

The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives.

Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide.

Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where access to quality healthcare is often limited. The condition is characterized by recurring seizures, which can have a significant impact on a person's quality of life. Effective diagnosis and treatment of epilepsy require advanced monitoring devices that can detect and track seizures in real-time.

In the U.S. alone, over 3 million individuals are estimated to be living with epilepsy. Further, in 2021, about 2.9 million U.S. adults 18 and older reported having active epilepsy, as per the U.S. Centers for Disease Control and Prevention.

The advancement of wearable technology and data analytics has revolutionized the field of epilepsy monitoring devices. The introduction of smartwatches and fitness trackers equipped with seizure detection algorithms has enabled the continuous monitoring of a patient's physiological data, including heart rate, movement, and electrodermal activity. This allows for detecting potential seizure episodes in real-time, providing patients and healthcare providers with timely and accurate information to make informed decisions about treatment and management. For instance, in February 2024, Empatica Inc., a pioneering company in continuous, non-invasive, and discreet monitoring for neurological conditions, announced the launch of EpiMonitor. This latest innovation in wearable epilepsy monitoring solutions is designed for adults and children aged 6 and above, offering cutting-edge technology that provides unparalleled convenience and accuracy in detecting and managing seizures.

Furthermore, growing government initiatives such as funding and investments for epilepsy research are expected to fuel the market's growth over the forecast period. For instance, Epilepsy Research Institute UK announced that the UK government has invested over USD 1.89 million in grant funding into Epilepsy Research UK through its Medical Research Charities Early Career Researchers Support Fund. The charity received USD 1.35 million in 2022-23 and USD 562,010.5 in 2021-22. Further, in March 2024, the British Epilepsy Association announced a USD 48.66 million investment into research for cancer, dementia, and epilepsy.

Global Epilepsy Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global epilepsy monitoring devices market report based on product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Wearable Devices
• Conventional Devices
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Neurology Centers
• Diagnostic Centers
• Regional Outlook (Revenue in USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. End Use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Epilepsy Monitoring Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidents of venom-bites
    • 3.2.1.2. Increasing R&D initiatives
    • 3.2.1.3. Increasing awareness about importance of Epilepsy monitoring devices
    • 3.2.1.4. Rising government initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited access to the treatments
• 3.3. Epilepsy monitoring devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Epilepsy Monitoring Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Epilepsy Monitoring Devices Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Wearable Devices
    • 4.4.1.1. Wearable devices market estimates and forecasts 2018 to 2030, (USD Million)
  • 4.4.2. Conventional Devices
    • 4.4.2.1. Conventional devices market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 5. Epilepsy Monitoring Devices Market: End Use Estimates & Trend Analysis

• 5.1. End Use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Epilepsy Monitoring Devices Market by End Use Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Hospitals & Clinics
    • 5.4.1.1. Hospitals market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.4.2. Ambulatory Surgical Centers
    • 5.4.2.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.4.3. Neurology Centers
    • 5.4.3.1. Neurology Centers market estimates and forecasts 2018 to 2030, (USD Million)
  • 5.4.4. Diagnostic Centers
    • 5.4.4.1. Diagnostic Centers market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 6. Epilepsy Monitoring Devices Market: Regional Estimates & Trend Analysis By Product, By End-use

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. North America
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030, (USD Million)
• 6.6. Europe
  • 6.6.1. Europe
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ Reimbursement
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. UK market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ Reimbursement
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ Reimbursement
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. France market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ Reimbursement
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework/ Reimbursement
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Denmark market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Regulatory framework
    • 6.6.9.3. Competitive scenario
    • 6.6.9.4. Norway market estimates and forecasts 2018 to 2030, (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ Reimbursement
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ Reimbursement
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. China market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ Reimbursement
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. India market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ Reimbursement
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.6. South Korea
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework/ Reimbursement
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Regulatory framework/ Reimbursement
    • 6.7.7.3. Competitive scenario
    • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030, (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework/ Reimbursement
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030, (USD Million)
• 6.9. MEA
  • 6.9.1. MEA
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework/ Reimbursement
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework/ Reimbursement
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework/ Reimbursement
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030, (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Regulatory framework
    • 6.9.5.3. Competitive scenario
    • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. NIHON KOHDEN CORPORATION
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Others benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Medtronic
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Others benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. GE Healthcare
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Others benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Koninklijke Philips N.V.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Others benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Compumedics Limited
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Others benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Natsu Medical
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Others benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Cadwell Industries, Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Others benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. BrainScope Company, Inc.
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Others benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Seer Medical
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Others benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Stratus
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Others benchmarking
    • 7.3.13.4. Strategic initiatives